SCHEMBL13415774

SCHEMBL13415774

CC(=O)c1ccc2cc3ncccc3cc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ HTT P42858 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ PLK1 P53350 1/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ NPC1 O15118 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ POLB P06746 3/20 0.44
▸ MAPT P10636 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NR4A2 P43354 1/20 0.43
▸ RAB9A P51151 3/20 0.42
▸ CASP6 P55212 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20572033 0.81 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHTTALOX15
SCHEMBL14806709 0.80 KMT2A (0.60) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL21608895 0.78 NPC1 (0.47) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL123373 0.77 KDM4E (0.71) ALDH1A1MEN1KMT2AHTTALOX15
SCHEMBL9729083 0.76 KDM4E (0.42) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL9360254 0.76 MEN1 (0.55) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL810236 0.76 LMNA (0.57) ALDH1A1MEN1KMT2AHTTALOX15
SCHEMBL29977567 0.76 MEN1 (0.55) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL150476 0.75 NPC1 (0.65) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL29350099 0.75 NPC1 (0.65) ALDH1A1MEN1KMT2ACASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140158998-A1 ORGANOMETALLIC COMPLEXES, AND ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2014-06-12 — — US disclosed
US-7687626-B2 highly efficient phosphorescent organometallic complex and an organic electroluminescent (EL) device using the same. The organometallic complex can be used in the formation of an organic layer of the organic EL device, and can emit red light from phosphorescent material SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-03-30 — — US disclosed
US-20080103308-A1 highly efficient phosphorescent organometallic complex and an organic electroluminescent (EL) device using the same. The organometallic complex can be used in the formation of an organic layer of the organic EL device, and can emit red light from phosphorescent material SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103308-A1 highly efficient phosphorescent organometallic complex and an organic electroluminescent (EL) device using the same. The organometallic complex can be used in the formation of an organic layer of the organic EL device, and can emit red light from phosphorescent material LAGE3, ORC3, ELOC ALDH1A1 3186/4885MEN1 581/4885KMT2A 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback